Viewpoint: Linking free markets to innovation is why capitalism is on the verge of defeating COVID

Credit: Sebastian Thibault
Credit: Sebastian Thibault

J&J’s road to the vaccine—from failure to life-saving success, from investment write-off to breakthrough—is a little-known story about science, business risk and innovation. There are also lessons for those who think capitalism is merely about rapacious profit.

“We would never be in the position where we are today if we had not invested billions of dollars over decades so that we could respond,” [said Johnson & Johnson CEO Alex] Gorsky.

In 2009, J&J entered into a partnership with Crucell to develop a vaccine it hoped could someday prevent infection from all influenza strains. Two years later, J&J bought Crucell for $2.4 billion.


“At that time we had little to no experience in vaccines,” Mr. Gorsky says. But capitalism entails risk: Many Crucell vaccine studies failed… Still, Crucell brought along “two really important technologies that gave seed to what we’re doing today.”

One was the AdVac platform. The other was the PER.C6 manufacturing technology, capable of mass-producing vaccines quickly and cheaply. 

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

“I think this is a golden moment, not only for Johnson & Johnson, but the biopharmaceutical industry,” [Gorsky] says. “We fundamentally believe that having a market-based, innovation-based, biopharmaceutical as well as a medical-technology environment, is critical long term to produce the best overall outcomes for healthcare.”


Read the original post

Related article:  WHO COVID investigative team finds evidence suggesting first infections occurred in October 2019 or earlier
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend